A randomized placebo-controlled trial to determine the effect of iron supplementation on hematological indices in pregnant women with hemoglobin =13.2 g/dl
Not Applicable
- Conditions
- Pregnant women of high hemoglobin.Abnormal haematological finding on antenatal screening of mother
- Registration Number
- IRCT138710181531N1
- Lead Sponsor
- Tarbiat Modarres University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 87
Inclusion Criteria
Pregnant women with Hb = 13.2 g/dl in the early stage of the second trimester, body mass index (BMI) between 19.8 and 26 kg/m2, single pregnancy, age between 17 and 35 years
Exclusion criteria: Falling Hb to less than 10.5 g/dl in the second trimester or 11 g/dl in the third trimester, history of any renal, hepatic, thyroid, or cardiac diseases, presence of diabetes, asthma, hypertension, or inflammatory diseases, presence of severe nausea and vomiting of pregnancy, smoking, substance abuse, history of threatened abortion
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hematologic indices. Timepoint: Baseline, at gestational weeks 24 -28 and 32-36. Method of measurement: Cell Blood Count with sismex k1000.
- Secondary Outcome Measures
Name Time Method